Efficacy and safety of implantation of multiple drug-eluting stents.
- Author:
Qiang FU
1
;
Zhi-Liang LI
;
Hong-Chao WU
Author Information
- Publication Type:Journal Article
- MeSH: Angioplasty, Balloon, Coronary; adverse effects; methods; Coronary Artery Disease; therapy; Coronary Restenosis; diagnosis; etiology; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Retrospective Studies; Treatment Outcome
- From: Journal of Southern Medical University 2008;28(1):110-112
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo assess the efficacy and safety of implantation of multiple drug-eluting stents.
METHODSA retrospective study of 151 cases was conducted, including 34 with implantation of at least 3 drug-eluting stents in the coronary artery (MS group), 53 with implantation of two stents (TS group), and 64 with a single stent (OS group). The incidence of major adverse cardiovascular event (MACE) and restenosis was evaluated.
RESULTSNo significant difference was found between the 3 groups in the incidence of MACE or in the stent thrombosis rate 30 days after the implantation. Follow-up of the patients for 6 months still showed comparable restenosis rate and MACE incidence between the 3 groups.
CONCLUSIONImplantation of multiple drug-eluting stents does not increase the risk of restenosis or MACE, and has comparable safety and efficacy with implantation of single and two stents.
